Denise Daire

Responsible for the launch of Bayer's new medication, Kerendia. A sales specialist that collaborates with Nephrologists and Cardiologists to raise education and awareness about Chronic Kidney Disease and Diabetes. Ensure the consistent delivery of comprehensive account sales calls to the entire staff and partner with Field Reimbursement specialists to assist staff with appeals and claims. Collaborating with colleagues to train on disease state and product knowledge, develop and implement effective business strategies for success.

• Finished 2021 as the top specialist in my region and top 20% in the area
• Regional Veeva Champ
• Q1 2022 MVP
• Field Sales Trainer
• 2023 Summer Blitz Winner
• Q3 2023 MVP
• Continually exceeded 100% to goal
• Finished 2023 ranked 20 out of 146
• Kulture Club Member
• Q1 2024 attained 113% to goal
• Q2 2024 on track to attain over 100% to goal

Start-up organization, responsible for creating disease awareness around metabolic acidosis to the Nephrology community for a product launch. The product was on an accelerated track; however, it received a clinical review letter, which resulted in the launch being delayed and the dissolution of the field force.

• Lead the nation in Virtual programs
• Collaborated and trained colleagues on disease awareness and effective business strategies

• Responsible for the sales of a biologic. Comprehensive office visits with Rheumatologist and Endocrinologists to provide education on Osteoporosis. Collaborated with a Nurse Educator to ensure proper patient education, compliance, and HCP/patient clinical knowledge.
• Southeast Market Access lead
• Sales Trainer
• 2018-Attained over 100% to goal within first six months.
• 2019-Awarded TOP 15 Tymlos market share
• 2020-Attained 124% to goal. Finished ranked #4 in the nation and #1 in my region.
• 2020-Awarded to performer for highest product volume in territory.

Responsible for sales of Protonix and Effexor XR in Miami, collaborating with Gastroenterologist and General Practitioners. Teamed up with the Specialty Representative to increase growth and volume. Visited pharmacies for product information and formulary status updates.

• 2007- Top 5 in the nation for achievement to goal and volume with both products.
• Assisted with business strategy planning for the region.

• Oversaw the sales of Lotrel, Miacalcin, and Famvir, collaborating extensively with cardiologists, primary care physicians, and infectious disease specialists. Successfully launched Zelnorm to gastroenterologist. Delivered sales achievements by leveraging product expertise, innovative selling techniques, business analytics, and strong relationships. Partnered with specialty representatives and colleagues across various functions for strategic business planning.
• Miami District delegate
• Sales Trainer for the Miami District
• Certified Medical Representative
• 2000-Awarded Gold Winner of the Week consecutively
• 2000-Awarded TOP 10 in the Atlantic Region for all products
• 2001-Awarded TOP 10 in the Atlantic Region and #1 with Lotrel in the Miami District
• 2001-Awarded Highest Market Share Growth in Atlantic Region
• 2002-Awarded for attaining #1 in market share for launch of Zelnorm in Atlantic Region
• 2003-Awarded for highest growth in volume for Zelnorm in Atlantic Region .
• Q1 2004 Awarded for continued market share growth for all products.